Physiological Reports · 2019 · 57 citations · 16 references
Life SciencesEndocrinologyPhysiologyAnimal PhysiologyMetabolic PhysiologyMetabolic RegulationDiabetes MellitusGluconeogenesis RegulationGlucose HomeostasisInsulin ResistanceRodent EndocrinologyRodent PhysiologyGlucose Metabolism EffectsHepatic Fuel MetabolismHepatic Glucose ProductionHepatic Glucose UptakeHepatic Insulin ResistanceHepatic Metabolic RegulationMuscle Fuel MetabolismObesity-associated Insulin Resistance
Adropin is a liver- and brain-secreted peptide hormone with striking effects on fuel metabolism regulation in a number of tissues. Previous studies demonstrated that adropin secretion is decreased in obese mice subjected to a long-term high-fat diet (HFD), and that whole-body loss of adropin expression resulted in systemic insulin resistance. Treatment of obese mice with adropin improves glucose tolerance, which has been linked to increased glucose oxidation and inhibition of fatty acid utilization in isolated skeletal muscle homogenates. In this study, we used in vivo physiological measurements to determine how treatment of obese mice with adropin affects whole-body glucose metabolism. Treatment with adropin reduced fasting blood glucose and, as shown previously, increased glucose tolerance in HFD mice during standard glucose tolerance tests. Under hyperinsulinemic-euglycemic clamp conditions, adropin treatment led to a nonsignificant increase in whole-body insulin sensitivity, and a significant reduction in whole-body glucose uptake. Finally, we show that adropin treatment suppressed hepatic glucose production and improved hepatic insulin sensitivity. This correlated with reduced expression of fatty acid import proteins and gluconeogenic regulatory enzymes in the liver, suggesting that adropin treatment may impact the pathways that drive vital aspects of hepatic glucose metabolism.
16
Adropin Is a Novel Regulator of Endothelial Function
Fina Lovren, Yi Pan, Adrian Quan et al. · Circulation · 2010 · 307 citations · Full text
Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance
K. Ganesh‐Kumar, Jingying Zhang, Su Gao et al. · Obesity · 2012 · 256 citations · Full text
SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
Michael J. Jurczak, Hui‐Young Lee, Andreas L. Birkenfeld et al. · Diabetes · 2011 · 220 citations · Full text
Andrew A. Butler, Charmaine S. Tam, Kimber L. Stanhope et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 198 citations · Full text
Medicine, Endocrinology, Physiology +14